Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

RhyGaze AG

History from 6 May 2024

UID
CHE-465.094.830
Legal form
AG
Canton
BS
Founded
6 May 2024
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 975k
244k488k732k975k7 Jun 2024 · CHF 268k13 Dec 2024 · CHF 649k30 Apr 2026 · CHF 975k20252026
  • shares
  • Vorzugsaktien Serie S
  • Vorzugsaktien S
  • Vorzugsaktien A

Record

  1. Company formed

    Founded 6 May 2024

    SHAB HR01-1006029055 ↗
  2. Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    108’000 → 268’333.34
    Shares
    10’800’000 → 26’833’334
    New shares, % of post-step shares
    59.8% (16’033’334 new)
    Share classes
    13’500’000 × CHF 0.01 · 13’333’334 × CHF 0.01 Vorzugsaktien Serie S

    Aktienkapital neu: CHF 268'333.34 [bisher: CHF 108'000.00]. Liberierung Aktienkapital neu: CHF 268'333.34 [bisher: CHF 108'000.00]. Aktien neu: 13'500'000 Namenaktien zu CHF 0.01 und 13'333'334 Namenaktien zu CHF 0.01 (Vorzugsaktien Serie S) [bisher: 10'800'000 Namenaktien zu CHF 0.01].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1006051104 ↗
  3. Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    268’333.34 → 649’057.80
    Shares
    26’833’334 → 64’905’780
    New shares, % of post-step shares
    58.7% (38’072’446 new)
    Share classes
    13’500’000 × CHF 0.01 · 13’333’334 × CHF 0.01 Vorzugsaktien S · 38’072’446 × CHF 0.01 Vorzugsaktien A

    Aktienkapital neu: CHF 649'057.80 [bisher: CHF 268'333.34]. Liberierung Aktienkapital neu: CHF 649'057.80 [bisher: CHF 268'333.34]. Aktien neu: 13'500'000 Namenaktien zu CHF 0.01, 13'333'334 Namenaktien zu CHF 0.01 (Vorzugsaktien S) und 38'072'446 Namenaktien zu CHF 0.01 (Vorzugsaktien A) [bisher: 13'500'000 Namenaktien zu CHF 0.01 und 13'333'334 Namenaktien zu CHF 0.01 (Vorzugsaktien Serie S)].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1006204402 ↗
  4. Capital increase

    Likely financing

    Paid in cash

    Nominal capital
    649’057.80 → 975’393.05
    Shares
    64’905’780 → 97’539’305
    New shares, % of post-step shares
    33.5% (32’633’525 new)
    Share classes
    13’500’000 × CHF 0.01 · 13’333’334 × CHF 0.01 Vorzugsaktien S · 70’705’971 × CHF 0.01 Vorzugsaktien A

    Aktienkapital neu: CHF 975'393.05 [bisher: CHF 649'057.80]. Liberierung Aktienkapital neu: CHF 975'393.05 [bisher: CHF 649'057.80]. Aktien neu: 13'500'000 Namenaktien zu CHF 0.01, 13'333'334 Namenaktien zu CHF 0.01 (Vorzugsaktien S) und 70'705'971 Namenaktien zu CHF 0.01 (Vorzugsaktien A) [bisher: 13'333'334 Namenaktien zu CHF 0.01 (Vorzugsaktien S), 38'072'446 Namenaktien zu CHF 0.01 (Vorzugsaktien A) und 13'500'000 Namenaktien zu CHF 0.01].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.90 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006639100 ↗

Published by 3 May 2026

Latest available record · 8 Oct 2026